Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-10-01 Sale |
2021-10-05 5:01 pm |
Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer |
50,000 | $4.89 | $244,500 | 49,587 (Direct) |
View |
| 2021-09-20 Sale |
2021-09-22 5:00 pm |
Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer |
25,000 | $4.97 | $124,250 | 99,587 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-10 Option Award |
2022-03-14 5:01 pm |
N/A 2032-03-10 |
Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer |
124,700 | $0 | 143,700 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-05 5:01 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer |
50,000 | $0.92 | 49,587 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-05 5:01 pm |
N/A 2026-09-14 |
Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer |
50,000 | $0 | 49,587 (Direct) |
View |
| 2021-09-20 Exercise |
2021-09-22 5:00 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer |
25,000 | $0.92 | 99,587 (Direct) |
View |
| 2021-09-20 Exercise |
2021-09-22 5:00 pm |
N/A 2026-09-14 |
Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer |
25,000 | $0 | 99,587 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 7:08 pm |
N/A 2031-02-25 |
Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer |
101,000 | $0 | 101,000 (Direct) |
View |